MPZL3 Inhibitors
MPZL3 inhibitors are chemical compounds that can influence the functional activity of MPZL3 by targeting specific signaling pathways or cellular processes. The action of these inhibitors is predicated on the understanding that the activity of MPZL3 relies on its phosphorylation state, which is controlled by various kinases. For instance, Staurosporine, a well-known kinase inhibitor, can reduce the phosphorylation of proteins like MPZL3 by inhibiting protein kinase C. This reduction in phosphorylation would likely lead to a decrease in the functional activity of MPZL3 as phosphorylation is often a regulatory mechanism for protein activity.
Similarly, the Src family kinase inhibitor PP2 can also lead to decreased MPZL3 activity by preventing Src kinases from phosphorylating MPZL3 or its associated substrates. Dasatinib, another broad-spectrum tyrosine kinase inhibitor, can impede the phosphorylation of tyrosine residues on proteins including MPZL3, whichis essential for their activation. Dasatinib's broad kinase inhibition spectrum means it can reduce MPZL3 activity by limiting its phosphorylation. In a similar vein, inhibitors targeting the PI3K/AKT/mTOR pathway, such as LY294002 and Wortmannin, by impeding PI3K, can lead to a reduction in MPZL3 activity since the PI3K pathway is often upstream of proteins like MPZL3. Rapamycin's inhibition of mTOR, a central protein in cell growth and proliferation, can also lead to decreased MPZL3 activity because mTOR pathways can regulate proteins involved in these processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinase C (PKC) which can reduce the phosphorylation of many substrates, including MPZL3. Reduced phosphorylation of MPZL3 would likely diminish its functional activity as phosphorylation is often crucial for protein function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Since Src kinases can phosphorylate tyrosine residues and potentially activate downstream proteins like MPZL3, PP2 inhibition of Src kinases can lead to reduced activation of MPZL3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K activation is part of a pathway that can lead to the activation of proteins like MPZL3. By inhibiting PI3K, LY294002 can prevent the activation of MPZL3 thereby reducing its functional activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor, which can inhibit the activation of downstream proteins that rely on tyrosine phosphorylation such as MPZL3, thereby reducing its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and proliferation pathways that may regulate proteins like MPZL3. Inhibition of mTOR by Rapamycin can lead to decreased function of MPZL3. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor which prevents the activation of ERK, a kinase that could phosphorylate substrates like MPZL3. By inhibiting MEK, U0126 can lead to a reduction in MPZL3 functional activity through decreased phosphorylation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK, SB203580 can reduce the phosphorylation of proteins involved in inflammatory responses, potentially including MPZL3, leading to its decreased activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which phosphorylates substrates involved in apoptosis and other cell processes. By inhibiting JNK, SP600125 can reduce the functional activity of proteins like MPZL3 that may be regulated by JNK activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can prevent the activation of ERK pathway. Since MPZL3 might be activated by ERK-mediated phosphorylation, inhibition by PD98059 can result in decreased MPZL3 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor similar to LY294002. By inhibiting PI3K, Wortmannin can reduce the activation of downstream proteins like MPZL3, leading to a decrease in its functional activity. | ||||||